Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

Tagged antitrust · clear

Patexia Insight 213: The Revlimid Dispute From Antitrust Battles to Patent Litigation

Revlimid (lenalidomide) , developed by Celgene Corporation, has been a groundbreaking treatment for multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma since its FDA approval in 2005. The drug has also been at the center of complex legal…

July 25, 2024Pharma & ANDA3 min read

Unsorted

From Monopoly to Competition: The Intersection of Patent and Antitrust Law in Promoting Market Efficiency

In a free market economy, competition is essential for promoting innovation, improving product quality, and providing consumers with greater choice and better prices. However, competition can also lead to anti-competitive behavior and the formation of…

March 15, 2023Unsorted1 min read